Americans with lung cancer are living longer, according to a new report from the American Lung Association, but researchers ...

Les Ferdinand is backing a partnership between Prostate Cancer UK and the MOBO Awards 2025 - which will take place in ...

Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

For Humphry Leue, the Cancer Screening Project he helped launch last week is meaningful on a very personal level. “I myself ...

Genetically predicted rheumatoid arthritis is causally associated with prostate cancer, according to study findings.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

An emergency physician has pinpointed a trio of "worrying" symptoms that might signal a lethal cancer accountable for nearly ...

Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to prostate cancer poster session. Dr. Zachary Klaassen presented the results of a population-based analysis evaluating ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $17.4 billion, has announced results from its Phase 3 TALAPRO-2 study which show that a combination of ...